Juan Sierra Madero

机构：Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán

发表论文 37 篇 · 总被引 1387 次 · h-index 14

代表论文

• Dolutegravir plus lamivudine versus dolutegravir plus tenofovir disoproxil fumarate and emtricitabine in antiretroviral-naive adults with HIV-1 infection (GEMINI-1 and GEMINI-2): week 48 results from two multicentre, double-blind, randomised, non-inferiority, phase 3 trials (2018 · The Lancet · 被引 385)
• Durable Efficacy of Dolutegravir Plus Lamivudine in Antiretroviral Treatment–Naive Adults With HIV-1 Infection: 96-Week Results From the GEMINI-1 and GEMINI-2 Randomized Clinical Trials (2019 · JAIDS Journal of Acquired Immune Deficiency Syndromes · 被引 214)
• Comparison of Kaposi Sarcoma Risk in Human Immunodeficiency Virus-Positive Adults Across 5 Continents: A Multiregional Multicohort Study (2017 · Clinical Infectious Diseases · 被引 63)
• Favipiravir in patients hospitalised with COVID-19 (PIONEER trial): a multicentre, open-label, phase 3, randomised controlled trial of early intervention versus standard care (2022 · The Lancet Respiratory Medicine · 被引 58)
• Pulmonary effects of immediate versus deferred antiretroviral therapy in HIV-positive individuals: a nested substudy within the multicentre, international, randomised, controlled Strategic Timing of Antiretroviral Treatment (START) trial (2016 · The Lancet Respiratory Medicine · 被引 44)
• Tecovirimat for the Treatment of Mpox (2026 · New England Journal of Medicine · 被引 24)